NIRMIDAS AND INNOPSYS – PARTNERSHIP SUCCESS STORY

Since many years, Nirmidas and Innopsys work toogether to offer high tech solutions as Nirmidas Biotech pGOLDTM assay. It is an innovative microarray platform for viral infections screening and protein biomarkers analysis (Zika, Dengue and SARS-CoV-2, among others). Nirmidas’ technology use proprietary gold-coated slides based on nanotechnology. This technology gives superior sensitivity and precision for…

PEPTIDE ARRAYS AND SYNTHETIC VACCINE

Peptide arrays technology is an ideal tool to identify epitopes and develop synthetic vaccine. Vaccination, one of the main work of Jenner in the 18th century, aims to stimulate immune responses against pathogens and microbes. This is the most effective method for protecting individuals from infections. Persistent vaccination has eradicated some diseases as smallpox .…

PMDA INNOSCAN SCANNER NOTIFICATION IN JAPAN

We are proud to anounce that our InnoScan 710-AL was notified to PMDA as a medical device. PMDA (Pharmaceuticals and Medical Devices Agency) is Japanese regulatory agency, working together with Ministry of Health, Labour and Welfare. Their obligation is to protect the public health by assuring safety, efficacy and quality of pharmaceuticals and medical devices.…